跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
AG-PERINDOPRIL ERBUMINE
Authorized
STANDARD
AG-PERINDOPRIL ERBUMINE
angita pharma inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
a7a1e83efebc5693
Company
angita pharma inc.
Type
Standard
Approval Details
Approval Id
a7a1e83efebc5693
Drug Approval Canada Name
AG-PERINDOPRIL ERBUMINE
Product Name
AG-PERINDOPRIL ERBUMINE
Status
Marketed
Status Date
2022-12-16
Original Market Date
2022-12-16
Din
02529513
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:32.04
Atc Original
C09AA04 PERINDOPRIL
Atc Name
c 09 aa 04
Aig Number
0127178003
Company Name
angita pharma inc.
Company Address
1310 Rue Nobel, Boucherville, Quebec, Canada, J4B 5H3
Active Ingredients
PERINDOPRIL ERBUMINE
8 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
a7a1e83efebc5693
Type
Standard
Back to Health Canada Approvals
AG-PERINDOPRIL ERBUMINE - Health Canada Drug Approval Details